Clinical approach to nonmotor sensory fluctuations in Parkinson's disease

UNLABELLED Many nonmotor fluctuations (NMFs) may occur in addition to the classic motor fluctuations (MFs) in patients with Parkinson's disease (PD) within several years of initiation of dopaminergic treatment. Patients can experience these NMFs in the "on" and/or "off" periods. NMFs can be divided into three groups: Autonomic, cognitive/psychiatric, and sensory. Nonmotor sensory fluctuations (NMSFs) occurring in association with "on" period are more frequently recognized than those in the "off" state. NMSFs commonly reported include pain, numbness, paresthesia/dysesthesia, akathisia, rest-legs syndrome (RLS), dyspnea, and internal tremor (IT). Proposed treatments of NMSFs are based on whether they occur during "off" or "on" state. These include reduction of dopaminergic medication, use of long-acting dopamine agonists or controlled released levodopa (LD), surgical intervention, and/or targeted pharmacological intervention to minimize dopaminergic side effects. NMSFs might be related to dopaminergic mechanisms although difficulty in managing these symptoms with dopaminergic therapy suggests a different pathway. CONCLUSION Recognition of NMSFs is important in the care of patients with Parkinson disease to prevent unnecessary interventions and for appropriate medication regimen adjustments.

[1]  Copeman Pw,et al.  PERIODIC BREATHING OF PREMATURE INFANTS. , 1964 .

[2]  K. Chaudhuri,et al.  Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome , 1999, Acta neurologica Scandinavica.

[3]  G. Schott Pain in Parkinson's disease , 1985, Pain.

[4]  C. Tanner,et al.  Pain in Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.

[5]  S. Factor,et al.  Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[6]  C. Marsden,et al.  PAINFUL PARKINSON'S DISEASE , 1986, The Lancet.

[7]  J. Burgunder,et al.  Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. , 2002, Journal of neurosurgery.

[8]  C. Marsden,et al.  LITHIUM FOR PAINFUL DYSTONIA IN PARKINSON'S DISEASE , 1986, The Lancet.

[9]  N. Quinn Classification of fluctuations in patients with Parkinson's disease , 1998, Neurology.

[10]  R. Carasso,et al.  Respiratory Muscle Performance and the Perception of Dyspnea in Parkinson's Disease , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[11]  G. Linazasoro,et al.  Nocturnal akathisia in parkinson's disease: Treatment with clozapine , 1993, Movement disorders : official journal of the Movement Disorder Society.

[12]  W. Koller,et al.  Sensory symptoms in Parkinson's disease , 1984, Neurology.

[13]  W. Weiner,et al.  Internal tremor in patients with Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[14]  J. Sage Pain in Parkinson’s disease , 2004, Current treatment options in neurology.

[15]  J. Penney,et al.  Striatal inhomogeneities and basal ganglia function , 1986, Movement disorders : official journal of the Movement Disorder Society.

[16]  S. Fahn,et al.  Oral and genital pain syndromes in Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[17]  N. Tuncer,et al.  The Clinical Profile of Nonmotor Fluctuations in Parkinson's Disease Patients , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  M. Cosio,et al.  Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. , 1989, Chest.

[19]  A. Lang,et al.  The spectrum of levodopa‐related fluctuations in Parkinson's disease , 1993, Neurology.

[20]  P. Sonsalla,et al.  Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug‐induced chorea , 1991, Annals of neurology.

[21]  A. Benabid,et al.  Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  G. Nappi,et al.  “Off” painful dystonia in Parkinson's disease treated with botulinum toxin , 1995, Movement disorders : official journal of the Movement Disorder Society.

[23]  C. Honey,et al.  Unilateral pallidotomy for reduction of parkinsonian pain. , 1999, Journal of neurosurgery.

[24]  C. Goetz,et al.  Akathisia in Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.

[25]  F. Raudino Non motor off in Parkinson's disease , 2001, Acta neurologica Scandinavica.

[26]  G. Lopez,et al.  Nonmotor fluctuations in Parkinson's disease: Clinical spectrum and classification , 2010, Journal of the Neurological Sciences.

[27]  A. Lang,et al.  Akathisia in idiopahic Parkinson's disease , 1987, Neurology.

[28]  G. Wooten,et al.  Progress in understanding the pathophysiology of treatment‐related fluctuations in Parkinson's disease , 1988 .

[29]  W. Weiner,et al.  Parkinson's Disease: Diagnosis and Clinical Management , 2007 .

[30]  Mark Stacy,et al.  Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment , 2005, Movement disorders : official journal of the Movement Disorder Society.

[31]  L. Cote,et al.  Primary sensory symptoms in parkinsonism , 1976, Neurology.

[32]  Richard P Allen,et al.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.

[33]  A. Lees A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease. , 1987, European neurology.

[34]  A. Lees,et al.  Baclofen in Parkinson's disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[35]  M. Ceccaldi,et al.  Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.

[36]  Basic mechanisms of motor fluctuations. , 1994, Neurology.

[37]  A J Lees,et al.  Dopamine agonists in Parkinson's disease: a look at apomorphine , 1993, Fundamental & clinical pharmacology.

[38]  Pattern of Non-Motor Fluctuations in Patients of Parkinson's Disease , 2009 .

[39]  J. Sage,et al.  Nonmotor fluctuations in patients with Parkinson's disease , 1996, Neurology.

[40]  A L Benabid,et al.  From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. , 1999, Brain : a journal of neurology.